Stay updated with breaking news from Takeshi urano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kishida has signaled that the central government will expedite the review process to pave the way for a swift approval if the drug's efficacy and safety are confirmed. ....
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms. ....
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind. ....
Failing to accelerate the rollout of booster shots may lead to a new wave of infections that could far surpass that of the fifth wave over the summer, a study has shown. ....
~ The development of drugs to treat COVID-19 is accelerating. Of particular interest are drugs that use “neutralizing antibodies” to prevent the virus from multiplying. These antibodies are artificially produced using gene recombination technology, and, when administered to patients, can defend against severe cases of the disease. While this type of drug is already being used in other countries, Japan’s Ministry of Health, Labor and Welfare (MHLW) is expected to approve an “antibody cocktail therapy” developed by United States- and Europe-based pharmaceutical companies and marketed by Chugai Pharmaceutical Co. before the end of July. With seemingly no end to the pandemic in sight, many hope this “wonder drug” will prove to be a game-changer. ....